Security key
74275C304
Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)
CUSIP: 74275C304
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 106,332
- Total 13F value
- $251,474
- Share change
- +106,332
- SEC-reported price per share
- $2.36
- Number of holders
- 10
- Value change
- +$251,474
- Number of buys
- 10
- Shares outstanding
- 2,857,143
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
10
Top holders
10
PCSA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Processa Pharmaceuticals, Inc. SEC filings
Processa Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74275C304
Recent filing periods:
Ownership snapshot
Top reported holders of PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
CITADEL ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
3/4/5
Highest disclosed value: $105,536
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CITADEL ADVISORS LLC has the largest disclosed position value at $105.5K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
CITADEL ADVISORS LLC
$105.5K
VANGUARD GROUP INC
$78.5K
Robert Michael Floyd
$51.6K
Virgil Thompson
$42.2K
GEODE CAPITAL MANAGEMENT, LLC
$40.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$105,536
315,410 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$78,515
234,653 shares
|
— | 31 Dec 2023 |
| Robert Michael Floyd |
3/4/5
Chief Operating Officer
|
—
class O/S missing
|
$51,618
172,061 shares
|
— | 09 Feb 2023 |
| Virgil Thompson |
3/4/5
Director
|
—
mixed-class rows
|
$42,163
241,907 shares
mixed-class rows
|
— | 27 Jun 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$40,832
122,033 shares
|
— | 31 Dec 2023 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$26,808
80,023 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
106,332
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q3 2025 Across Filers
Q3 2025 holders
13
Q1 2024 holders
10
Holder diff
-3
| Investor | Q3 2025 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend